CoChat

Inhibition of Vascular Endothelial Growth Factor Reduces Scar Formation after Glaucoma Filtration Surgery

Open access
Li, Zhongqiu, Van Bergen, Tine, Van de Veire, Sara, Van de Vel, Isabelle, Moreau, Huberte, Dewerchin, Mieke, Maudgal, Prabhat C., Zeyen, Thierry, Spileers, Werner, Moons, Lieve, Stalmans, Ingeborg · 2009 · Investigative Opthalmology & Visual Science

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

PURPOSE: Filtration failure due to excessive postoperative scarring remains a major problem after glaucoma surgery. The authors have investigated whether glaucoma and filtration surgery are associated with increased levels of vascular endothelial growth factor (VEGF), and whether a humanized monoclonal antibody against VEGF, bevacizumab, can reduce postoperative scar formation and improve surgical outcome. METHODS: The levels of VEGF in samples of aqueous humor were measured by ELISA. The expression of the VEGF receptors Flt-1 and KDR was analyzed in cultured Tenon fibroblasts by real-time RT-PCR and Western blotting. The effect of VEGF and bevacizumab on Tenon fibroblasts in vitro was determined using a proliferation assay. The in vivo effect of the antibody was investigated in a rabbit model of trabeculectomy by measuring the intraocular pressure (IOP) and bleb area, and by immunohistological analysis of angiogenesis, inflammation, and fibrosis. RESULTS: VEGF levels were increased significantly in the aqueous humor of glaucoma patients and rabbits that had undergone surgery. Both VEGF receptors were expressed on Tenon fibroblasts. Fibroblast proliferation in vitro was stimulated by delivery of VEGF, and was inhibited by administration of bevacizumab. The antibody also reduced angiogenesis and collagen deposition significantly, and improved the outcome of glaucoma surgery in rabbits. CONCLUSIONS: VEGF was upregulated in the aqueous humor of glaucoma patients and in the rabbit model, and it stimulated fibroblast proliferation in vitro. This suggests that it is involved in the scarring process after filtration surgery. Bevacizumab reduced the proliferation of fibroblasts in vitro and improved surgical outcome.

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.08-2662

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Cited by

Items 101–200 of 246

Metadata

Authors
Li, Z., Van Bergen, T., Van de Veire, S., Van de Vel, I., Moreau, H., Dewerchin, M., Maudgal, P. C., Zeyen, T., Spileers, W., Moons, L., & Stalmans, I.
Affiliations
  • Capital Medical University (CN)
  • From the Laboratory of Ophthalmology, and
  • From the Laboratory of Ophthalmology, and 4Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium;
  • ThromboGenics NV, Leuven, Belgium;
  • Vlaams Instituut voor Biotechnologie (BE)
  • Universitair Ziekenhuis Leuven (BE)
  • KU Leuven (BE)
Corresponding author
  • Li, Zhongqiu
  • Moreau, Huberte
  • Dewerchin, Mieke
  • Maudgal, Prabhat C.
  • Zeyen, Thierry
  • Spileers, Werner
  • Moons, Lieve
  • Stalmans, Ingeborg
Venue
Investigative Opthalmology & Visual Science
Published
2009-11-01
Volume
50
Issue
11
Pages
5217
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W2004845166
Cited by
223
References
55
Citations by year
2026: 5 · 2025: 5 · 2024: 5 · 2023: 19 · 2022: 11 · 2021: 9 · 2020: 18 · 2019: 16 · 2018: 11 · 2017: 16 · 2016: 16 · 2015: 19 · 2014: 18 · 2013: 18 · 2012: 19
FWCI
12.55
Type
journal article
Language
en
Open access
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion)
Funders
U.S. Food and Drug Administration
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Health Sciences › Medicine › Ophthalmology › Corneal surgery and disorders
  • Health Sciences › Medicine › Ophthalmology › Intraocular Surgery and Lenses
Keywords
vascular endothelial growth factor, bevacizumab, glaucoma filtration surgery, trabeculectomy, postoperative scarring, aqueous humor, Tenon fibroblasts, VEGF receptors, angiogenesis, fibrosis, collagen deposition, intraocular pressure, blebs
MeSH terms
Bevacizumab, Animals, Anterior Chamber, Antibodies, Monoclonal, Aqueous Humor, Cells, Cultured, Cicatrix, Conjunctival Diseases, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Fibroblasts, Glaucoma, Open-Angle, Humans, Injections, Intraocular Pressure, Postoperative Complications, Rabbits, Tonometry, Ocular, Trabeculectomy, Reverse Transcriptase Polymerase Chain Reaction, Angiogenesis Inhibitors, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Cell Proliferation, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.